Ajanta Pharma informs about revised disclosure

15 Dec 2023 Evaluate
Ajanta Pharma has informed that it enclosed revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 15, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2760.00 34.85 (1.28%)
31-Dec-2025 11:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.90
Dr. Reddys Lab 1266.70
Cipla 1498.45
Zydus Lifesciences 909.90
Lupin 2093.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×